好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C177 - The Global Burden of Neurologic Diseases

Wednesday 04/29/20
07:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Cumara B. O'Carroll, MD, FAAN
Global Health and Neuroepidemiology
Participants will be familiar with the burden of common neurological conditions such as stroke and epilepsy in low and middle-income countries, as well as practical and innovative solutions. Participants will have increased awareness of the neurological conditions affecting refugees and internally displaced persons, as well as the importance of providing culturally sensitive and guideline-based care.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Introductory
Fellow, Resident, General Neurologist
Didactic
Event Timeline
07:00 AM - 07:35 AM Speaker Neurology in Refugees and Asylum Seekers
Farrah J. Mateen, MD, PhD, FAAN
07:35 AM - 08:10 AM Speaker Burden of Stroke in Resource-Limited Settings
Cumara B. O'Carroll, MD, FAAN
08:10 AM - 08:45 AM Speaker The Disease that Shall Not Be Named: Epilepsy Care and Research in Zambia
Omar Siddiqi, MD
08:45 AM - 09:00 AM Q&A Questions & Discussion
Faculty Disclosures
Cumara B. O'Carroll, MD, FAAN Dr. O'Carroll has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Omar Siddiqi, MD The institution of Dr. Siddiqi has received research support from NIH.